Literature DB >> 22380810

Evaluation of cystoscopic-guided laser ablation of intramural ectopic ureters in female dogs.

Allyson C Berent1, Chick Weisse, Philipp D Mayhew, Kimberly Todd, Monika Wright, Demetrius Bagley.   

Abstract

OBJECTIVE: To describe and evaluate the short- and long-term outcomes in female dogs after cystoscopic-guided laser ablation of ectopic ureters (CLA-EU).
DESIGN: Prospective case series. ANIMALS: 32 incontinent female dogs with intramural ectopic ureters. PROCEDURES: A diagnosis of intramural ectopic ureters was made via cystoscopy and fluoroscopy in all patients. Transurethral CLA-EU (via diode laser [n = 27] or Holmium:yttrium aluminum garnet laser [3]) was performed to relocate the ectopic ureteral orifice cranially into the urinary bladder. All vaginal anomalies were treated with the laser concurrently. Follow-up evaluation was standardized and included urinary continence scoring, serial bacteriologic culture of urine samples, and a follow-up cystoscopy 6 to 8 weeks after CLA-EU.
RESULTS: Ectopic ureteral orifices of all dogs were initially located in the urethra. Eighteen of 30 dogs had bilateral ectopic ureters, and 12 had unilateral ectopic ureters. All dogs had other concurrent urinary anomalies. At the time of last follow-up (median, 2.7 years after CLA-EU, [range, 12 to 62 months]), 14 of 30 (47%) dogs did not require any additional treatments following CLA-EU to maintain urinary continence. For the 16 residually incontinent dogs, the addition of medical management, transurethral bulking-agent injection, or placement of a hydraulic occluder was effective in 3, 2, and 4 dogs, respectively, improving the overall urinary continence rate to 77% (23/30 dogs). One dog had evidence of polypoid cystitis at the neoureteral orifice 6 weeks after CLA-EU that was resolved at 3 months. CONCLUSIONS AND CLINICAL RELEVANCE: CLA-EU provided an effective, safe, and minimally invasive alternative to surgery for intramural ectopic ureters in female dogs.

Entities:  

Mesh:

Year:  2012        PMID: 22380810     DOI: 10.2460/javma.240.6.716

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  7 in total

1.  Presumptive malignant transformation of chronic polypoid cystitis into an apical transitional cell carcinoma without BRAF mutation in a young female dog.

Authors:  Emmanuelle Marie Butty; Shelley Hahn; Mary Anna Labato
Journal:  J Vet Intern Med       Date:  2021-03-19       Impact factor: 3.333

2.  Evaluation of urethral stent placement for benign urethral obstructions in dogs.

Authors:  T L Hill; A C Berent; C W Weisse
Journal:  J Vet Intern Med       Date:  2014-07-28       Impact factor: 3.333

3.  Endoscopic laser-ablation for the treatment of orthotopic and ectopic ureteroceles in dogs: 13 cases (2008-2017).

Authors:  Cleo P Rogatko; Allyson C Berent; Larry G Adams; Chick W Weisse; Demetrius Bagley
Journal:  J Vet Intern Med       Date:  2019-02-11       Impact factor: 3.333

4.  Transurethral cystoscopy in dogs with recurrent urinary tract infections: Retrospective study (2011-2018).

Authors:  Marie Llido; Catherine Vachon; Melanie Dickinson; Guy Beauchamp; Marilyn Dunn
Journal:  J Vet Intern Med       Date:  2020-02-26       Impact factor: 3.333

5.  Monopolar electrocautery use in minimally invasive urosurgery: Case report of ectopic ureter management in a bitch.

Authors:  Evelina Burbaitė; Vytautas Sabūnas; Vytautas Stankus; Ernest Kostenko; Rūta Karalienė
Journal:  Open Vet J       Date:  2022-03-15

6.  Diagnostic yield of uroendoscopy compared to ultrasonography for evaluating lower urinary tract disorders in dogs.

Authors:  Emmelyn S Hsieh; Carrie Palm; Gilad Segev; Eric G Johnson; Kaitlin Leung; Jodi L Westropp
Journal:  J Vet Intern Med       Date:  2022-08-19       Impact factor: 3.175

7.  Retrospective evaluation of cystoscopic-guided laser ablation of intramural ectopic ureters in female dogs.

Authors:  Kimberly S Hooi; Catherine Vachon; Dorothee V Martel; Marilyn Dunn
Journal:  J Vet Intern Med       Date:  2021-12-08       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.